Fleury and Hermes Pardini merger authorized by Cade

The Administrative Council for Economic Defense (Cade) denied a prominent request that could prolong the
Read More

Hermes Pardini reinforces oncology space with acquisition

In its fourth M&A move in 2022, the diagnostic medicine group from Minas Gerais buys
Read More

Hermes Pardini launches B2B market to extend its addressable market

Waiting for the merger with Fleury, Hermes Pardini puts on the market a marketplace whose
Read More